(4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone

C133H129BrN16O6 — CID 159837236

IUPAC(4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone
SMILESCOc1ccc(-c2ccc3[nH]c(C(=O)N4CCN(C(c5ccccc5)c5ccccc5)CC4)cc3c2)cc1.Cc1ccc2[nH]c(C(=O)N3CCN(Cc4ccccc4)CC3)cc2c1.O=C(c1cc(Br)c[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(c1cc2cc(-c3ccccc3)ccc2[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(c1nc2ccccc2[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1
InChIInChI=1S/C33H31N3O2.C32H29N3O.C25H24N4O.C22H22BrN3O.C21H23N3O/c1-38-29-15-12-24(13-16-29)27-14-17-30-28(22-27)23-31(34-30)33(37)36-20-18-35(19-21-36)32(25-8-4-2-5-9-25)26-10-6-3-7-11-26;36-32(30-23-28-22-27(16-17-29(28)33-30)24-10-4-1-5-11-24)35-20-18-34(19-21-35)31(25-12-6-2-7-13-25)26-14-8-3-9-15-26;30-25(24-26-21-13-7-8-14-22(21)27-24)29-17-15-28(16-18-29)23(19-9-3-1-4-10-19)20-11-5-2-6-12-20;23-19-15-20(24-16-19)22(27)26-13-11-25(12-14-26)21(17-7-3-1-4-8-17)18-9-5-2-6-10-18;1-16-7-8-19-18(13-16)14-20(22-19)21(25)24-11-9-23(10-12-24)15-17-5-3-2-4-6-17/h2-17,22-23,32,34H,18-21H2,1H3;1-17,22-23,31,33H,18-21H2;1-14,23H,15-18H2,(H,26,27);1-10,15-16,21,24H,11-14H2;2-8,13-14,22H,9-12,15H2,1H3
InChIKeyNOFUNOABYLKNLN-UHFFFAOYSA-N
MW2127.50 g/mol
LogP24.64
Rot. Bonds22

About (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone

(4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone (PubChem CID 159837236) has the molecular formula C133H129BrN16O6 and a molecular weight of 2127.50 g/mol. Its IUPAC name is (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone.

Molecular Properties

Compound Name(4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone
PubChem CID159837236
Molecular FormulaC133H129BrN16O6
Molecular Weight2127.50 g/mol
Exact Mass2124.95
IUPAC Name(4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone
SMILESCOc1ccc(-c2ccc3[nH]c(C(=O)N4CCN(C(c5ccccc5)c5ccccc5)CC4)cc3c2)cc1.Cc1ccc2[nH]c(C(=O)N3CCN(Cc4ccccc4)CC3)cc2c1.O=C(c1cc(Br)c[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(c1cc2cc(-c3ccccc3)ccc2[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(c1nc2ccccc2[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1
InChIInChI=1S/C33H31N3O2.C32H29N3O.C25H24N4O.C22H22BrN3O.C21H23N3O/c1-38-29-15-12-24(13-16-29)27-14-17-30-28(22-27)23-31(34-30)33(37)36-20-18-35(19-21-36)32(25-8-4-2-5-9-25)26-10-6-3-7-11-26;36-32(30-23-28-22-27(16-17-29(28)33-30)24-10-4-1-5-11-24)35-20-18-34(19-21-35)31(25-12-6-2-7-13-25)26-14-8-3-9-15-26;30-25(24-26-21-13-7-8-14-22(21)27-24)29-17-15-28(16-18-29)23(19-9-3-1-4-10-19)20-11-5-2-6-12-20;23-19-15-20(24-16-19)22(27)26-13-11-25(12-14-26)21(17-7-3-1-4-8-17)18-9-5-2-6-10-18;1-16-7-8-19-18(13-16)14-20(22-19)21(25)24-11-9-23(10-12-24)15-17-5-3-2-4-6-17/h2-17,22-23,32,34H,18-21H2,1H3;1-17,22-23,31,33H,18-21H2;1-14,23H,15-18H2,(H,26,27);1-10,15-16,21,24H,11-14H2;2-8,13-14,22H,9-12,15H2,1H3
InChIKeyNOFUNOABYLKNLN-UHFFFAOYSA-N
XLogP24.64
TPSA218.82 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds22
Heavy Atoms156
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002127.50
LogP ≤ 524.64
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Analyze (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone?
The IUPAC name of (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone (CID 159837236) is (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone.
What is the SMILES notation for (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone?
The canonical SMILES for (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone is COc1ccc(-c2ccc3[nH]c(C(=O)N4CCN(C(c5ccccc5)c5ccccc5)CC4)cc3c2)cc1.Cc1ccc2[nH]c(C(=O)N3CCN(Cc4ccccc4)CC3)cc2c1.O=C(c1cc(Br)c[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(c1cc2cc(-c3ccccc3)ccc2[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(c1nc2ccccc2[nH]1)N1CCN(C(c2ccccc2)c2ccccc2)CC1.
What is the InChIKey of (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone?
The InChIKey is NOFUNOABYLKNLN-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H31N3O2.C32H29N3O.C25H24N4O.C22H22BrN3O.C21H23N3O/c1-38-29-15-12-24(13-16-29)27-14-17-30-28(22-27)23-31(34-30)33(37)36-20-18-35(19-21-36)32(25-8-4-2-5-9-25)26-10-6-3-7-11-26;36-32(30-23-28-22-27(16-17-29(28)33-30)24-10-4-1-5-11-24)35-20-18-34(19-21-35)31(25-12-6-2-7-13-25)26-14-8-3-9-15-26;30-25(24-26-21-13-7-8-14-22(21)27-24)29-17-15-28(16-18-29)23(19-9-3-1-4-10-19)20-11-5-2-6-12-20;23-19-15-20(24-16-19)22(27)26-13-11-25(12-14-26)21(17-7-3-1-4-8-17)18-9-5-2-6-10-18;1-16-7-8-19-18(13-16)14-20(22-19)21(25)24-11-9-23(10-12-24)15-17-5-3-2-4-6-17/h2-17,22-23,32,34H,18-21H2,1H3;1-17,22-23,31,33H,18-21H2;1-14,23H,15-18H2,(H,26,27);1-10,15-16,21,24H,11-14H2;2-8,13-14,22H,9-12,15H2,1H3.
What are the key properties of (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone?
(4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone has a molecular weight of 2127.50 g/mol, XLogP of 24.64, 22 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (4-benzhydrylpiperazin-1-yl)-(1H-benzimidazol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-(4-bromo-1H-pyrrol-2-yl)methanone;(4-benzhydrylpiperazin-1-yl)-[5-(4-methoxyphenyl)-1H-indol-2-yl]methanone;(4-benzhydrylpiperazin-1-yl)-(5-phenyl-1H-indol-2-yl)methanone;(4-benzylpiperazin-1-yl)-(5-methyl-1H-indol-2-yl)methanone is sourced from PubChem (CID 159837236), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).